Evidence map›Paper›PMID 28973862›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

De novo design of covalently constrained mesosize protein scaffolds with unique tertiary structures.

Bobo Dang, Haifan Wu, Vikram Khipple Mulligan, Marco Mravic, Yibing Wu, Thomas Lemmin, Alexander Ford, Daniel-Adriano Silva, David Baker, William F DeGrado

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 74 citations in OpenAlex.

  1. Multicyclic D-Stereospecific Hydrolase Dimer With High Sustained Activity.Angewandte Chemie (International ed. in English) · 2026
    Article
  2. Inhibition of ice recrystallization with designed twistless helical repeat proteins.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Article
  5. Heuristic energy-based cyclic peptide design.PLoS computational biology · 2025
    Article
  6. Heuristic energy-based cyclic peptide design.bioRxiv : the preprint server for biology · 2025
    Article
  7. Article
  8. Review
  9. De novo design of monomeric helical bundles for pH-controlled membrane lysis.Protein science : a publication of the Protein Society · 2023
    Article
  10. Article
  11. Design and Engineering of Miniproteins.ACS bio & med chem Au · 2022
    Review
  12. Article
  13. Article
  14. Protein Macrocyclization for Tertiary Structure Stabilization.Chembiochem : a European journal of chemical biology · 2021
    Review
  15. Article
  16. Transferrin receptor targeting by de novo sheet extension.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  17. Article
  18. Article
  19. Computationally designed peptide macrocycle inhibitors of New Delhi metallo-β-lactamase 1.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Bobo DangDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158.ORCID 0000-0003-1962-8677
Haifan WuDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158.
Vikram Khipple MulliganDepartment of Biochemistry, University of Washington, Seattle, WA 98195.
Marco MravicDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158.
Yibing WuDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158.
Thomas LemminDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158.
Alexander FordDepartment of Biochemistry, University of Washington, Seattle, WA 98195.
Daniel-Adriano SilvaDepartment of Biochemistry, University of Washington, Seattle, WA 98195.
David BakerDepartment of Biochemistry, University of Washington, Seattle, WA 98195.
William F DeGradoDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158; william.degrado@ucsf.edu.
University of California, San Francisco · USUniversity of Washington · US

Funding

X-ray Screening and Rapid Structure DeterminationP50GM082250 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FRANKEL, ALAN D · 2007 to 2018
$48.8M
Yeast ExpressionP50GM073210 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STROUD, ROBERT M · 2004 to 2013
$21.5M
STRUCTURAL BIOLOGY TRAINING PROGRAMT32GM008284 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KORTEMME, TANJA · 1988 to 2022
$10.1M
Project 6 (Holton)U54GM094625 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STROUD, ROBERT M · 2010 to 2014
$8.0M
Deciphering the relationship between structure, dynamics and function in helical bundle proteinsR35GM122603 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WILLIAM DEGRADO · 2017 to 2026
$7.1M
De novo design of alpha-helical bundlesR37GM054616 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI DEGRADO, WILLIAM · 2004 to 2013
$3.6M
DE NOVO DESIGN OF ALPHA HELICAL BUNDLESR01GM054616 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI DEGRADO, WILLIAM · 1996 to 2016
$2.4M
MINOS (Macromolecular Insights on Nucleic acids Optimized by Scattering)R01GM105404 · NIGMS · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI TAINER, JOHN A. · 2012 to 2015
$2.1M
NIGMS NIH HHS P50 GM073210NIGMS NIH HHS P50 GM082250NIGMS NIH HHS R01 GM054616NIGMS NIH HHS R01 GM105404NIGMS NIH HHS R35 GM122603NIGMS NIH HHS R37 GM054616NIGMS NIH HHS T32 GM008284NIGMS NIH HHS U54 GM094625
6 · The paper itself

Abstract

The folding of natural proteins typically relies on hydrophobic packing, metal binding, or disulfide bond formation in the protein core. Alternatively, a 3D structure can be defined by incorporating a multivalent cross-linking agent, and this approach has been successfully developed for the selection of bicyclic peptides from large random-sequence libraries. By contrast, there is no general method for the de novo computational design of multicross-linked proteins with predictable and well-defined folds, including ones not found in nature. Here we use Rosetta and Tertiary Motifs (TERMs) to design small proteins that fold around multivalent cross-linkers. The hydrophobic cross-linkers stabilize the fold by macrocyclic restraints, and they also form an integral part of a small apolar core. The designed CovCore proteins were prepared by chemical synthesis, and their structures were determined by solution NMR or X-ray crystallography. These mesosized proteins, lying between conventional proteins and small peptides, are easily accessible either through biosynthetic precursors or chemical synthesis. The unique tertiary structures and ease of synthesis of CovCore proteins indicate that they should provide versatile templates for developing inhibitors of protein-protein interactions.

Indexed as

Protein FoldingProtein Structure, SecondaryAmino Acid SequenceCoronavirusCrystallography, X-RayHumansModels, MolecularProtein EngineeringSequence HomologyViral Core ProteinsViral Core Proteinschemical protein synthesiscomputational designcovalent coremesosize proteinprotein design

Identifiers

PMID28973862
PMCPMC5642715
OpenAlexW2763971786

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.